RPAM
Rhenman & Partners Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.7M | Buy |
51,197
+3,000
| +6% | +$978K | 2.11% | 17 |
|
|
2025
Q1 | $13M | Buy |
48,197
+31,197
| +184% | +$8.42M | 1.5% | 27 |
|
|
2024
Q4 | $4M | Sell |
17,000
-33,350
| -66% | -$7.85M | 0.41% | 61 |
|
|
2024
Q3 | $13.8M | Sell |
50,350
-35,150
| -41% | -$9.67M | 1.12% | 32 |
|
|
2024
Q2 | $20.8M | Buy |
85,500
+43,200
| +102% | +$10.5M | 1.99% | 17 |
|
|
2024
Q1 | $6.32M | Buy |
42,300
+4,800
| +13% | +$717K | 0.6% | 51 |
|
|
2023
Q4 | $7.18M | Sell |
37,500
-7,500
| -17% | -$1.44M | 0.72% | 48 |
|
|
2023
Q3 | $7.97M | Hold |
45,000
| – | – | 0.86% | 40 |
|
|
2023
Q2 | $8.55M | Sell |
45,000
-31,000
| -41% | -$5.89M | 0.9% | 38 |
|
|
2023
Q1 | $14.8M | Buy |
76,000
+3,000
| +4% | +$585K | 1.63% | 22 |
|
|
2022
Q4 | $17.3M | Sell |
73,000
-2,000
| -3% | -$475K | 1.81% | 22 |
|
|
2022
Q3 | $15.5M | Hold |
75,000
| – | – | 1.63% | 24 |
|
|
2022
Q2 | $10.9M | Sell |
75,000
-55,000
| -42% | -$8.02M | 1.24% | 33 |
|
|
2022
Q1 | $21.2M | Sell |
130,000
-45,000
| -26% | -$7.35M | 2.09% | 14 |
|
|
2021
Q4 | $29.9M | Buy |
175,000
+75,000
| +75% | +$12.8M | 1.99% | 15 |
|
|
2021
Q3 | $18.9M | Sell |
100,000
-35,000
| -26% | -$6.61M | 1.33% | 28 |
|
|
2021
Q2 | $22.9M | Hold |
135,000
| – | – | 1.55% | 23 |
|
|
2021
Q1 | $19.1M | Buy |
135,000
+23,300
| +21% | +$3.29M | 1.33% | 34 |
|
|
2020
Q4 | $14.5M | Buy |
111,700
+11,700
| +12% | +$1.52M | 1.18% | 37 |
|
|
2020
Q3 | $14.6M | Buy |
100,000
+37,905
| +61% | +$5.52M | 1.29% | 33 |
|
|
2020
Q2 | $9.2M | Sell |
62,095
-17,905
| -22% | -$2.65M | 0.99% | 41 |
|
|
2020
Q1 | $8.71M | Buy |
80,000
+19,285
| +32% | +$2.1M | 1.22% | 35 |
|
|
2019
Q4 | $6.99M | Sell |
60,715
-8,285
| -12% | -$954K | 0.77% | 54 |
|
|
2019
Q3 | $5.55M | Sell |
69,000
-12,550
| -15% | -$1.01M | 0.7% | 54 |
|
|
2019
Q2 | $5.92M | Sell |
81,550
-10,000
| -11% | -$726K | 0.65% | 55 |
|
|
2019
Q1 | $8.56M | Sell |
91,550
-20,000
| -18% | -$1.87M | 1% | 44 |
|
|
2018
Q4 | $8.13M | Sell |
111,550
-60,400
| -35% | -$4.4M | 0.93% | 45 |
|
|
2018
Q3 | $15M | Buy |
171,950
+57,983
| +51% | +$5.07M | 1.51% | 30 |
|
|
2018
Q2 | $11.2M | Buy |
113,967
+30,000
| +36% | +$2.95M | 1.15% | 42 |
|
|
2018
Q1 | $10M | Buy |
83,967
+25,000
| +42% | +$2.98M | 1.23% | 35 |
|
|
2017
Q4 | $7.49M | Buy |
58,967
+16,174
| +38% | +$2.05M | 1.01% | 42 |
|
|
2017
Q3 | $5.03M | Sell |
42,793
-37,397
| -47% | -$4.39M | 0.64% | 60 |
|
|
2017
Q2 | $6.4M | Sell |
80,190
-49,810
| -38% | -$3.97M | 0.92% | 40 |
|
|
2017
Q1 | $6.66M | Sell |
130,000
-5,000
| -4% | -$256K | 1.06% | 35 |
|
|
2016
Q4 | $5.05M | Buy |
135,000
+5,000
| +4% | +$187K | 0.97% | 39 |
|
|
2016
Q3 | $8.81M | Sell |
130,000
-65,000
| -33% | -$4.41M | 1.4% | 23 |
|
|
2016
Q2 | $10.8M | Buy |
195,000
+70,000
| +56% | +$3.88M | 1.92% | 16 |
|
|
2016
Q1 | $7.85M | Buy |
125,000
+63,000
| +102% | +$3.95M | 1.56% | 23 |
|
|
2015
Q4 | $5.84M | Sell |
62,000
-14,000
| -18% | -$1.32M | 0.88% | 46 |
|
|
2015
Q3 | $6.11M | Buy |
76,000
+14,600
| +24% | +$1.17M | 0.97% | 43 |
|
|
2015
Q2 | $7.36M | Buy |
61,400
+8,400
| +16% | +$1.01M | 0.88% | 31 |
|
|
2015
Q1 | $5.53M | Buy |
53,000
+30,000
| +130% | +$3.13M | 0.93% | 38 |
|
|
2014
Q4 | $2.23M | Buy |
23,000
+9,970
| +77% | +$967K | 0.65% | 69 |
|
|
2014
Q3 | $1.02M | Buy |
+13,030
| New | +$1.02M | 0.3% | 89 |
|